Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
3.360
+0.020 (0.60%)
Jan 21, 2025, 4:00 PM EST - Market open
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $4.55 million as of January 22, 2025. Its market cap has decreased by -9.34% in one year.
Market Cap
4.55M
Enterprise Value
-17.51M
1-Year Change
-9.34%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has decreased from $5.28M to $4.55M, a decrease of -13.76%. That is a compound annual growth rate of -3.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 4.55M | -3.17% |
| Dec 31, 2024 | 4.70M | -15.16% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |